PARSABIV
NDC 55513-740, etelcalcetide, injection, solution, from Amgen, Inc.
- Product NDC
- 55513-740
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208325
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETELCALCETIDE HYDROCHLORIDE2.5 mg/.5mL
Pharmacologic classes
Calcium-sensing Receptor Agonist [EPC]; Increased Calcium-sensing Receptor Sensitivity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-740-10 | 55513074010 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55513-740-10) / .5 mL in 1 VIAL, SINGLE-DOSE (55513-740-01) |
| 55513-740-20 | 55513074020 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55513-740-20) / .5 mL in 1 VIAL, SINGLE-DOSE (55513-740-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c
Use it
Look up 55513-740 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-740. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.